Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02879643
Title Vincristine Sulfate Liposome Injection (Marqibo) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapsed ALL
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Therapeutic Advances in Childhood Leukemia Consortium
Indications

childhood acute lymphocytic leukemia

acute leukemia

lymphoblastic lymphoma

Therapies

Dexamethasone + Methotrexate + Pegaspargase + Vincristine sulfate liposome

Dexamethasone + Mercaptopurine + Methotrexate + Vincristine sulfate liposome

Dexamethasone + Methotrexate + Mitoxantrone + Pegaspargase + Vincristine sulfate liposome

Age Groups: adult | child
Covered Countries USA | CAN


No variant requirements are available.